Gaipov A 3
101. Epidemiology of tuberculosis in Kazakhstan: data from the Unified National Electronic Healthcare System 2014-2019
102. The Prevalence, Indications, Outcomes of the Most Common Major Gynecological Surgeries in Kazakhstan and Recommendations for Potential Improvements into Public Health and Clinical Practice: Analysis of the National Electronic Healthcare System (2014–2019)
103. Intradialytic Changes and Prognostic Value of Ventriculo-Arterial Coupling in Patients With End-Stage Renal Disease: Protocol for an Observational Prospective Trial
104. Population health and health services: Old challenges and new realities in the COVID-19 era
105. Associations of Clusters of Cardiovascular Risk Factors with Insulin Resistance and Β-Cell Functioning in a Working-Age Diabetic-Free Population in Kazakhstan
106. New Therapeutic Approach to Reduce Methotrexate Toxicity after High-Dose Chemotherapy in a Child with Acute Lymphocytic Leukemia: Efficacy and Safety of Hemoadsorption with HA-230 Adsorber
107. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
108. Sensitive detection of kidney injury biomarker (KIM1) in urine samples using an optical fiber semi-distributed interferometer biosensor
109. Associations between medical education reforms and trends in the ophthalmology workforce and cataract surgery performance in Kazakhstan
110. Historical evolution of healthcare systems of post-soviet Russia, Belarus, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, Armenia, and Azerbaijan: A scoping review
111. Tetracyclines in the Modern Era: Global Consumption, Antimicrobial Resistance, Environmental Occurrence, and Degradation Techniques
112. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
113. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023
114. Symptomatic urinary stone disease in Kazakhstan: hospitalization trends from the national electronic healthcare system (2014–2021)
115. All-cause hospital admissions and incidence of asthma in children in Kazakhstan: a population-based retrospective cohort study
116. Epidemiology of Congenital Heart Disease in Kazakhstan: Data from the Unified National Electronic Healthcare System 2014-2021
117. Metabolically healthy obesity: Misleading phrase or healthy phenotype?
118. Detection of Cancer Biomarkers: Review of Methods and Applications Reported from Analytical Perspective
119. Review: Detection of Cancer Biomarkers from a Clinical Perspective
120. The impact of exercise on cardiovascular system: Molecular signaling pathway and cardiac adaptations
121. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
122. The value of machine and deep learning in management of critically ill patients: An umbrella review
123. Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
124. Epidemiological characteristics and climatic variability of viral meningitis in Kazakhstan, 2014–2019
125. Epidemiological characteristics and seasonal variation of measles, pertussis, and influenza in Kazakhstan between 2010-2020 years
126. Epidemiology of Arterial Hypertension in Kazakhstan: Data from Unified Nationwide Electronic Healthcare System 2014–2019
127. Seasonal and epidemiological profile of chickenpox cases in Kazakhstan
128. Angiopoietin as a Novel Prognostic Marker in Kidney Disease
129. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Newly Independent States and Russia
130. Analysis of chronic kidney disease epidemiology in Kazakhstan using nationwide data for 2014–2020 and forecasting future trends of prevalence and mortality for 2030
131. Heart failure burden in Kazakhstan among adults: data from Unified National Electronic Healthcare System 2014–19
132. Incidence and mortality rates of strokes in Kazakhstan in 2014–2019
133. Incidence, mortality and disability-adjusted life years of acute myocardial infarction in Kazakhstan: data from unified national electronic healthcare system 2014–2019
134. Temporal Trends and Mortality Patterns in Peripheral Arterial Disease: A Comprehensive Analysis of Hospitalized Patients in Kazakhstan between 2014 and 2021
135. The Regional Burden and Disability-Adjusted Life Years of Knee Osteoarthritis in Kazakhstan 2014–2020
136. Cardiac imaging in athlete’s heart: current status and future prospects
1 2 3 3